Travere Therapeutics (TVTX) Current Assets (2016 - 2025)
Historic Current Assets for Travere Therapeutics (TVTX) over the last 17 years, with Q3 2025 value amounting to $371.1 million.
- Travere Therapeutics' Current Assets rose 1427.91% to $371.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $371.1 million, marking a year-over-year increase of 1427.91%. This contributed to the annual value of $416.7 million for FY2024, which is 3243.86% down from last year.
- Per Travere Therapeutics' latest filing, its Current Assets stood at $371.1 million for Q3 2025, which was up 1427.91% from $379.6 million recorded in Q2 2025.
- In the past 5 years, Travere Therapeutics' Current Assets registered a high of $686.2 million during Q3 2023, and its lowest value of $324.7 million during Q3 2024.
- Its 5-year average for Current Assets is $509.6 million, with a median of $542.1 million in 2023.
- Its Current Assets has fluctuated over the past 5 years, first soared by 4201.2% in 2021, then plummeted by 5267.77% in 2024.
- Travere Therapeutics' Current Assets (Quarter) stood at $582.8 million in 2021, then dropped by 16.54% to $486.4 million in 2022, then increased by 26.79% to $616.8 million in 2023, then plummeted by 32.44% to $416.7 million in 2024, then fell by 10.94% to $371.1 million in 2025.
- Its Current Assets stands at $371.1 million for Q3 2025, versus $379.6 million for Q2 2025 and $374.2 million for Q1 2025.